Scancell founder says the company is ready to commercialise novel medicines to counteract cancer. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksInforma Regulatory News (INF)

Share Price Information for Informa (INF)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 842.00
Bid: 843.80
Ask: 844.20
Change: -5.00 (-0.59%)
Spread: 0.40 (0.047%)
Open: 844.20
High: 849.40
Low: 842.00
Prev. Close: 847.00
INF Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Form 8 (DD) - INFORMA PLC

15 Jun 2018 11:13

FORM 8 (DD)

PUBLIC DEALING DISCLOSURE BY A PARTY TO AN OFFER OR PERSON ACTING IN CONCERT (INCLUDING DEALINGS FOR THE ACCOUNT OF DISCRETIONARY INVESTMENT CLIENTS)

Rules 8.1, 8.2 and 8.4 of the Takeover Code (the “Code”)

1. KEY INFORMATION

(a) Full name of discloser: Barclays PLC.
(b) Owner or controller of interest and short
positions disclosed, if different from 1(a):
(c) Name of offeror/offeree in relation to whose INFORMA PLC
relevant securities this form relates:
(d) Status of person making the disclosure: CONNECTED TO OFFEROR
(e) Date position held/dealing undertaken: 14 June 2018
(f) In addition to the company in 1(c) above, is the discloser making NO
disclosures in respect of any other party to the offer?

2. POSITIONS OF THE PERSON MAKING THE DISCLOSURE

If there are positions or rights to subscribe to disclose in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 2(a) or (b) (as appropriate) for each additional class of relevant security.

(a) Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates following the dealing

Class of relevant security: ADR
Interests Short Positions
Number (%) Number (%)
(1) Relevant securities owned
and/or controlled: 47,500 0.01% 0 0.00%
(2) Cash-settled derivatives:
0 0.00% 0 0.00%
(3) Stock-settled derivatives (including options)
and agreements to purchase/sell: 0 0.00% 0 0.00%
(4)
TOTAL: 47,500 0.01% 0 0.00%

All interests and all short positions should be disclosed.

Details of any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions).

Details of any securities borrowing and lending positions or financial collateral arrangements should be disclosed on a Supplemental Form 8 (SBL).

(b) Rights to subscribe for new securities (including directors’ and other employee options)

Class of relevant security in relation to which subscription right exists:
Details, including nature of the rights concerned and relevant percentages:

3. DEALINGS BY THE PERSON MAKING THE DISCLOSURE

Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 3(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.

The currency of all prices and other monetary amounts should be stated.

(a) Purchases and sales

(i) Party to an offer or person acting in concert (except for a principal trader in the same group as a connected adviser)

Class of relevant Purchase/sale Number of Price per unit
security securities
ADR Purchase 700 22.1200 USD
ADR Sale 700 22.1200 USD

(ii) Principal trader where the sole reason for the connection is that the principal trader is in the same group as a connected adviser

Class of relevant security Purchases/ sales Total number of securities Highest price per unit paid/received Lowest price per unit paid/received

(b) Cash-settled derivative transactions

Class of relevant security Product description

e.g. CFD

Nature of dealing

e.g. opening/closing a long/short position, increasing/reducing a long/short position

Number of reference securities Price per unit

(c) Stock-settled derivative transactions (including options)

(i) Writing, selling, purchasing or varying

Class of relevant security Product description e.g. call option Writing, purchasing, selling, varying etc. Number of securities to which option relates Exercise price per unit Type

e.g. American, European etc.

Expiry date Option money paid/ received per unit

(ii) Exercise

Class of relevant security Product description

e.g. call option

Exercising/ exercised against Number of securities Exercise price per unit

(d) Other dealings (including subscribing for new securities)

Class of relevant security Nature of dealing

e.g. subscription, conversion

Details Price per unit (if applicable)

4. OTHER INFORMATION

(a) Indemnity and other dealing arrangements

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the party to the offer or person acting in concert making the disclosure and any other person:

Irrevocable commitments and letters of intent should not be included. If there are no such agreements, arrangements or understandings, state “none”

None

(b) Agreements, arrangements or understandings relating to options or derivatives

Details of any agreement, arrangement or understanding, formal or informal, between the party to the offer or person acting in concert making the disclosure and any other person relating to:

(i) the voting rights of any relevant securities under any option; or

(ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced:

If there are no such agreements, arrangements or understandings, state “none”

None

(c) Attachments

Are any Supplemental Forms attached?

Supplemental Form 8 (Open Positions) NO
Supplemental Form 8 (SBL) NO
Date of disclosure: 15 Jun 2018
Contact name: Femi Badmos
Telephone number: 020 3555 1125

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service.

The Panel’s Market Surveillance Unit is available for consultation in relation to the Code’s dealing disclosure requirements on +44 (0)20 7638 0129.

The Code can be viewed on the Panel’s website at www.thetakeoverpanel.org.uk.

View source version on businesswire.com: https://www.businesswire.com/news/home/20180615005284/en/

Copyright Business Wire 2018

Date   Source Headline
4th May 20209:11 amRNSResult of Meeting
30th Apr 20205:46 pmRNSTotal Voting Rights
22nd Apr 20207:00 amRNSDirector/PDMR Shareholding
21st Apr 20204:06 pmRNSHolding(s) in Company
20th Apr 20206:15 pmRNSHolding(s) in Company
17th Apr 20205:46 pmRNSNotice of GM
16th Apr 20206:25 pmRNSInforma
16th Apr 20204:24 pmRNSResults of Placing
16th Apr 20207:00 amRNSIssue of Equity
16th Apr 20207:00 amRNSTrading Update
8th Apr 20205:29 pmRNSHolding(s) in Company
6th Apr 20205:16 pmRNSSkipta Launches COVID-19 Forum & Lecture Series
6th Apr 202010:30 amRNSHolding(s) in Company
27th Mar 202010:59 amRNSDirector/PDMR Shareholding
26th Mar 20204:00 pmRNSHolding(s) in Company
26th Mar 20209:55 amRNSDirector/PDMR Shareholding
20th Mar 202012:00 pmRNSHolding(s) in Company
17th Mar 202012:15 pmRNSDirector/PDMR Shareholding
13th Mar 20206:00 pmRNSDirector/PDMR Shareholding
12th Mar 20206:15 pmRNSHolding(s) in Company
10th Mar 20207:00 amRNSInforma 2019 Full Year Results
23rd Jan 202010:11 amRNSDirector/PDMR Shareholding
10th Jan 202010:30 amRNSInforma adds F1000 Research to Taylor & Francis
7th Jan 202011:20 amRNSBoard Update
24th Dec 201911:22 amRNSDirector/PDMR Shareholding
18th Dec 20192:30 pmRNSDirector/PDMR Shareholding
18th Dec 20199:37 amRNSHolding(s) in Company
9th Dec 20199:39 amRNSNotice of Release of Guarantors to Noteholders
11th Nov 20197:00 amRNS10-Month Trading Update
25th Sep 201910:33 amRNSDirector/PDMR Shareholding
23rd Sep 201911:46 amRNSDirector/PDMR Shareholding
24th Jul 20197:00 amRNSHalf-year Report
19th Jul 20192:30 pmRNSBlock listing Interim Review and Cancellation
17th Jun 20197:00 amRNSRule 19.6(c) Confirmation
4th Jun 20195:57 pmRNSDirector/PDMR Shareholding
4th Jun 20195:53 pmRNSDirector/PDMR Shareholding
3rd Jun 20194:25 pmRNSDirector/PDMR Shareholding
24th May 20193:39 pmRNSResult of AGM
24th May 20197:00 amRNSAGM Trading Update
22nd May 20191:00 pmRNSPortfolio Agreement with IHS Markit
21st May 20194:50 pmRNSBoard Update
10th May 20197:00 amRNSInforma 2019 Investor Day
30th Apr 201912:13 pmRNSHolding(s) in Company
23rd Apr 20195:46 pmRNS2018 Annual Financial Report and Notice of AGM
18th Apr 201911:45 amRNSDirectorate Change
10th Apr 201910:31 amRNSHolding(s) in Company
4th Apr 201910:42 amRNSHolding(s) in Company
3rd Apr 20194:03 pmRNSDirector/PDMR Shareholding
28th Mar 201911:00 amRNSLaunch of Informa Ventures
22nd Mar 20193:25 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.